EyePoint Pharmaceuticals
EYPT
$19.74
Share price
-1.00%
Change (1 day)
201.83%
Change (1 year)
Categories
EyePoint Pharmaceuticals (EYPT) - Total debt
Total debt on the balance sheet as of December 2023 : $4.9 M
According to EyePoint Pharmaceuticals 's latest financial reports the company's total debt is $4.9 M. A company’s total debt is the sum of all current and non-current debts.
EyePoint Pharmaceuticals - Total debt on balance sheet (from 2006 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $4.9 M | -89.28% |
| 2022-12-31 | $45.76 M | 16.75% |
| 2021-12-31 | $39.2 M | -4.37% |
| 2020-12-31 | $40.99 M | -18.21% |
| 2019-12-31 | $50.12 M | |
| 2018-06-30 | $17.3 M | |
| 2006-06-30 | $11.25 M | |
| 2001-06-30 | $0.14 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.8 M | -83.59% | Bahamas |
 NRC Health
NRC | $36.68 M | 647.74% | 🇺🇸 USA |